Table 3.
Start M (Md) Q1-Q3* |
Completion M (Md) Q1-Q3 |
Follow-up M (Md) Q1-Q3 |
P-value
1
Sta-Com** |
P-value
1
Com-FU*** |
|
---|---|---|---|---|---|
All | N324 | N203 | N138 | ||
No hazardous use | 2.2 (2.0) 0.2–3.0 | 2.0 (1.1) 0.0–3.0 | 2.9 (2.0) 0.0–4.0 | 0.206 | 0.028 |
Hazardous | 12.3 (11.0) 8.9–16.0 | 7.9 (6.0) 4.4–12.0 | 8.3 (7.0) 3.5–11.0 | <0.001 | 0.286 |
Female | N226 | N151 | N103 | ||
No hazardous use | 1.9 (2.0) 0.8–3.0 | 1.7 (1.0) 0.0–3.0 | 2.5 (1.0) 0.0–3.0 | 0.364 | 0.141 |
Hazardous | 12.0 (11.0) 8.0–15.8 | 8.3 (7.0) 5.0–12.0 | 8.2 (7.5) 3.8–11.0 | <0.001 | 0.239 |
Male | N98 | N52 | N35 | ||
No hazardous use | 3.0 (3.0) 0.2–5.0 | 3.0 (3.0) 1.0–4.6 | 3.9 (4.0) 1.8–7.0 | 0.272 | 0.100 |
Hazardous | 12.9 (11.0) 9.0–16.0 | 6.9 (6.0) 3.0–8.2 | 8.6 (7.0) 4.5–13.0 | 0.005 | 0.780 |
Paired comparisons. Test used: 1Paired T-test. * Mean value (Median value) First and third quartiles. ** Start-completion. *** Completion-Follow-Up.